National Institute of Neurological Disorders and Stroke; Notice of Meeting, 11682-11683 [2015-04407]
Download as PDF
<![CDATA[
mstockstill on DSK4VPTVN1PROD with NOTICES
11682
Federal Register / Vol. 80, No. 42 / Wednesday, March 4, 2015 / Notices
to learn about possible modifications
before coming to the meeting.
Agenda: On March 24, 2015, the
Pediatric Advisory Committee (PAC)
will meet to discuss pediatric-focused
safety reviews, as mandated by the Best
Pharmaceuticals for Children Act (Pub.
L. 107–109) and the Pediatric Research
Equity Act (Pub. L. 108–155). The PAC
will meet to discuss the following
products: CYMBALTA (duloxetine
hydrochloride), QUILLIVANT XR
(methylphenidate hydrochloride),
LUNESTA (eszopiclone), RISPERDAL
(risperidone), OXTELLAR XR
(oxcarbazepine), REVATIO (sildenafil),
ADVAIR HFA (fluticasone propionate/
salmeterol), DYMISTA (azelastine
hydrochloride/fluticasone proprionate),
QNASL (beclomethasone dipropionate),
VENOFER (iron sucrose), INVIRASE
(saquinavir), ALTABAX Ointment
(retapamulin), FluMist
QUADRIVALENT (influenza vaccine
live, intranasal), FLUARIX
QUADRIVALENT (influenza virus
vaccine), Medtronic ACTIVA
DYSTONIA THERAPY, and
LIPOSORBER LA–15 System. In
addition, there will be a short
presentation of the ethical issues
discussed by the Pediatric Ethics
Subcommittee of the PAC on March 23,
2015.
FDA intends to make background
material available to the public no later
than 2 business days before the meeting.
If FDA is unable to post the background
material on its Web site prior to the
meeting, the background material will
be made publicly available at the
location of the advisory committee
meeting, and the background material
will be posted on FDA’s Web site after
the meeting. Background material is
available at https://www.fda.gov/
AdvisoryCommittees/Calendar/
default.htm. Scroll down to the
appropriate advisory committee link.
Procedure: Interested persons may
present data, information, or views,
orally or in writing, on issues pending
before the committee. Written
submissions may be made to the contact
person on or before March 16, 2015.
Oral presentations from the public will
be scheduled on March 24, 2015,
between approximately 9 a.m. and 10
a.m. Those individuals interested in
making formal oral presentations should
notify the contact person and submit a
brief statement of the general nature of
the evidence or arguments they wish to
present, the names and addresses of
proposed participants, and an
indication of the approximate time
requested to make their presentation on
or before March 6, 2015. Time allotted
for each presentation may be limited. If
VerDate Sep<11>2014
18:11 Mar 03, 2015
Jkt 235001
the number of registrants requesting to
speak is greater than can be reasonably
accommodated during the scheduled
open public hearing session, FDA may
conduct a lottery to determine the
speakers for the scheduled open public
hearing session. The contact person will
notify interested persons regarding their
request to speak by March 9, 2015.
Persons attending FDA’s advisory
committee meetings are advised that the
Agency is not responsible for providing
access to electrical outlets.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with physical
disabilities or special needs. If you
require special accommodations due to
a disability, please contact Walter
Ellenberg at least 7 days in advance of
the meeting.
FDA is committed to the orderly
conduct of its advisory committee
meetings. Please visit our Web site at
https://www.fda.gov/Advisory
Committees/AboutAdvisoryCommittees/
ucm111462.htm for procedures on
public conduct during advisory
committee meetings.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
Dated: February 26, 2015.
Jill Hartzler Warner,
Associate Commissioner for Special Medical
Programs.
[FR Doc. 2015–04394 Filed 3–3–15; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Center for Scientific
Review Special Emphasis Panel, March
05, 2015, 11:00 a.m. to March 05, 2015,
05:00 p.m., National Institutes of Health,
6701 Rockledge Drive, Bethesda, MD,
20892 which was published in the
Federal Register on February 24, 2015,
80 FR 9738.
The meeting will be held on March
12, 2015. The meeting location and time
remain the same. The meeting is closed
to the public.
Dated: February 25, 2015.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–04408 Filed 3–3–15; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Advisory Neurological
Disorders and Stroke Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Neurological Disorders and Stroke Council.
Date: May 28–29, 2015.
Open: May 28, 2015, 8:00 a.m. to 3:00 p.m.
Agenda: Report by the Director, NINDS;
Report by the Associate Director for
Extramural Research; Administrative and
Program Developments; and an Overview of
the NINDS Intramural Program.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Closed: May 28, 2015, 3:00 p.m. to 4:45
p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Closed: May 28, 2015, 4:45 p.m. to 5:15
p.m.
Agenda: To review and evaluate the
Division of Intramural Research Board of
Scientific Counselors’ Reports.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Closed: May 29, 2015, 8:00 a.m. to 11:00
a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Contact Person: Robert Finkelstein, Ph.D.,
Associate Director for Extramural Research,
E:\FR\FM\04MRN1.SGM
04MRN1
Federal Register / Vol. 80, No. 42 / Wednesday, March 4, 2015 / Notices
National Institute of Neurological Disorders
and Stroke, NIH, 6001 Executive Blvd., Suite
3309, MSC 9531, Bethesda, MD 20892, (301)
496–9248.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.ninds.nih.gov, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS).
Dated: February 25, 2015.
Carolyn Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–04407 Filed 3–3–15; 8:45 am]
BILLING CODE 4140–01–P
ADVISORY COUNCIL ON HISTORIC
PRESERVATION
Notice of Advisory Council on Historic
Preservation Quarterly Business
Meeting
Advisory Council on Historic
Preservation.
AGENCY:
Notice of Advisory Council on
Historic Preservation Quarterly Business
Meeting.
ACTION:
Notice is hereby given that
the Advisory Council on Historic
Preservation (ACHP) will hold its next
quarterly meeting on Thursday, March
19, 2015. The meeting will be held in
the Ortega Ballroom at the Officer’s Club
on Moraga Avenue, The Presidio, San
Francisco, California, starting at 8:00
a.m. PST.
mstockstill on DSK4VPTVN1PROD with NOTICES
SUMMARY:
The quarterly meeting will take
place on Thursday, March 19, 2015,
starting at 8:30 a.m. PST.
DATES:
The meeting will be held in
the Ortega Ballroom at the Officer’s Club
on Moraga Avenue, The Presidio, San
Francisco, California.
ADDRESSES:
VerDate Sep<11>2014
18:11 Mar 03, 2015
Jkt 235001
FOR FURTHER INFORMATION CONTACT:
Cindy Bienvenue, 202–517–0202,
cbienvenue@achp.gov.
SUPPLEMENTARY INFORMATION: The
Advisory Council on Historic
Preservation (ACHP) is an independent
federal agency that promotes the
preservation, enhancement, and
sustainable use of our nation’s diverse
historic resources, and advises the
President and the Congress on national
historic preservation policy. The goal of
the National Historic Preservation Act
(NHPA), which established the ACHP in
1966, is to have federal agencies act as
responsible stewards of our nation’s
resources when their actions affect
historic properties. The ACHP is the
only entity with the legal responsibility
to encourage federal agencies to factor
historic preservation into federal project
requirements. For more information on
the ACHP, please visit our Web site at
www.achp.gov.
The agenda for the upcoming
quarterly meeting of the ACHP is the
following:
Call to Order—8:00 a.m.
I. Chairman’s Welcome
II. Historic Preservation Policy and
Programs
A. Building a More Inclusive
Preservation Program
1. Asian-American Pacific Islander
Initiative
2. American Latino Heritage Initiative
B. Working with Native Americans
1. Presentation by California Tribes
2. ACHP Native American Affairs
Committee Activities
C. Preservation 50 and the ACHP
Public Policy Initiative
D. Historic Preservation Legislation in
the 114th Congress
1. ACHP Legislative Agenda
2. Policy for Adoption of ACHP
Legislative Positions
E. Clement Price Scholar Program
III. Section 106 Issues
A. 2015 Section 3 Report to the
President Implementation
B. Alignment of Section 4f and
Section 106 Reviews
C. Federal Agency Support for SHPOs
and THPOs
IV. ACHP Management Issues
A. Member CommunicationsRecommendations
V. New Business
VI. Adjourn
The meetings of the ACHP are open
to the public. If you need special
accommodations due to a disability,
please contact Cindy Bienvenue, 202–
517–0202 or cbienvenue@achp.gov, at
least seven (7) days prior to the meeting.
Authority: 16 U.S.C. 470j.
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
11683
Dated: February 27, 2015.
Javier E. Marques,
Associate General Counsel.
[FR Doc. 2015–04498 Filed 3–3–15; 8:45 am]
BILLING CODE 4310–K6–P
DEPARTMENT OF HOMELAND
SECURITY
[Docket No. DHS–2015–0007]
Office of Cybersecurity and
Communications, National Protection
and Programs Directorate Notice of
Meeting Regarding Information
Sharing and Analysis Organizations
Authority: 6 U.S.C. 131–134; 6 CFR. 29;
E.O. 13691.
Office of Cybersecurity and
Communications, National Protection
and Programs Directorate.
ACTION: Notice of Meeting.
AGENCY:
This Notice announces a
public meeting on March 18, 2015 to
discuss Information Sharing and
Analysis Organizations, cybersecurity
information sharing, and the Executive
Order 13691, ‘‘Promoting Private Sector
Cybersecurity Information Sharing’’ of
February 13, 2015.
DATES: The meeting will be held on
March 18, 2015, 9:00 a.m. to 11:30 a.m.
The meeting may conclude before the
allotted time if all matters for discussion
have been addressed. Submit comments
on or before April 19, 2015 at 11:59 p.m.
In the event DHS does not have
appropriations by 11:59 p.m. on March
16, 2015, this notice and the meeting is
cancelled.
ADDRESSES: The meeting location is in
Arlington—Navy League of the United
States, 2300 Wilson Boulevard,
Arlington, VA 22201. See
Supplementary Information section for
the address to submit written or
electronic comments.
FOR FURTHER INFORMATION CONTACT: If
you have questions concerning the
meeting, please contact ISAO@
hq.dhs.gov or Michael A. Echols,
Director, JPMO, Department of
Homeland Security, michael.echols@
dhs.gov.
SUPPLEMENTARY INFORMATION:
SUMMARY:
Background and Purpose
On February 13, 2015, President
Obama signed Executive Order 13691
intended to enable and facilitate
‘‘private companies, nonprofit
organizations, and executive
departments and agencies . . .to share
information related to cybersecurity
risks and incidents and collaborate to
E:\FR\FM\04MRN1.SGM
04MRN1
]]>Agencies
[Federal Register Volume 80, Number 42 (Wednesday, March 4, 2015)]
[Notices]
[Pages 11682-11683]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-04407]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice
of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
National Advisory Neurological Disorders and Stroke Council.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable materials, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Neurological Disorders and
Stroke Council.
Date: May 28-29, 2015.
Open: May 28, 2015, 8:00 a.m. to 3:00 p.m.
Agenda: Report by the Director, NINDS; Report by the Associate
Director for Extramural Research; Administrative and Program
Developments; and an Overview of the NINDS Intramural Program.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 10, Bethesda, MD 20892.
Closed: May 28, 2015, 3:00 p.m. to 4:45 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 10, Bethesda, MD 20892.
Closed: May 28, 2015, 4:45 p.m. to 5:15 p.m.
Agenda: To review and evaluate the Division of Intramural
Research Board of Scientific Counselors' Reports.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 10, Bethesda, MD 20892.
Closed: May 29, 2015, 8:00 a.m. to 11:00 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 10, Bethesda, MD 20892.
Contact Person: Robert Finkelstein, Ph.D., Associate Director
for Extramural Research,
[[Page 11683]]
National Institute of Neurological Disorders and Stroke, NIH, 6001
Executive Blvd., Suite 3309, MSC 9531, Bethesda, MD 20892, (301)
496-9248.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Information is also available on the Institute's/Center's home
page: https://www.ninds.nih.gov, where an agenda and any additional
information for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
Biological Basis Research in the Neurosciences, National Institutes
of Health, HHS).
Dated: February 25, 2015.
Carolyn Baum,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-04407 Filed 3-3-15; 8:45 am]
BILLING CODE 4140-01-P
